1. Home
  2. PRA vs PCRX Comparison

PRA vs PCRX Comparison

Compare PRA & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRA
  • PCRX
  • Stock Information
  • Founded
  • PRA 1976
  • PCRX 2006
  • Country
  • PRA United States
  • PCRX United States
  • Employees
  • PRA N/A
  • PCRX 790
  • Industry
  • PRA Property-Casualty Insurers
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRA Finance
  • PCRX Health Care
  • Exchange
  • PRA Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • PRA 1.2B
  • PCRX 1.2B
  • IPO Year
  • PRA N/A
  • PCRX 2011
  • Fundamental
  • Price
  • PRA $23.77
  • PCRX $26.45
  • Analyst Decision
  • PRA Hold
  • PCRX Buy
  • Analyst Count
  • PRA 4
  • PCRX 6
  • Target Price
  • PRA $21.00
  • PCRX $30.00
  • AVG Volume (30 Days)
  • PRA 446.0K
  • PCRX 666.0K
  • Earning Date
  • PRA 08-05-2025
  • PCRX 08-05-2025
  • Dividend Yield
  • PRA N/A
  • PCRX N/A
  • EPS Growth
  • PRA N/A
  • PCRX N/A
  • EPS
  • PRA 0.95
  • PCRX N/A
  • Revenue
  • PRA $1,128,928,000.00
  • PCRX $705,848,000.00
  • Revenue This Year
  • PRA N/A
  • PCRX $7.36
  • Revenue Next Year
  • PRA N/A
  • PCRX $10.07
  • P/E Ratio
  • PRA $25.04
  • PCRX N/A
  • Revenue Growth
  • PRA N/A
  • PCRX 2.25
  • 52 Week Low
  • PRA $12.43
  • PCRX $12.61
  • 52 Week High
  • PRA $24.14
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • PRA 46.88
  • PCRX 61.33
  • Support Level
  • PRA $23.62
  • PCRX $25.14
  • Resistance Level
  • PRA $23.87
  • PCRX $27.04
  • Average True Range (ATR)
  • PRA 0.11
  • PCRX 0.82
  • MACD
  • PRA -0.03
  • PCRX 0.07
  • Stochastic Oscillator
  • PRA 30.00
  • PCRX 69.49

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: